To increase access to pre-exposure prophylaxis to reduce the transmission of HIV.

# Summary of HR 7853 **What the Bill Would Do** HR 7853 aims to expand access to pre-exposure prophylaxis (PrEP), a medication that can prevent HIV infection in people who don't currently have the virus but are at higher risk of contracting it. The bill focuses on removing barriers that prevent people from obtaining this preventive treatment, though the specific provisions aren't detailed in the available information. **Who It Affects** This legislation would primarily benefit people at higher risk of HIV infection, including men who have sex with men, transgender individuals, and those in serodiscordant relationships (where one partner has HIV and the other doesn't).

It could also affect healthcare providers, insurance companies, and public health programs involved in distributing PrEP. **Current Status** The bill was introduced by Representative Mark Takano (D-CA) in the 119th Congress and is currently in committee, meaning it hasn't yet been debated or voted on by the full House. No specific provisions or implementation details are publicly available at this stage.